Basiliximab is associated with a lower incidence of De novo donor-specific HLA antibodies in kidney transplant recipients: A single-center experience.

Jarmi, Tambi; Abdelmoneim, Yousif; Li, Zhuo; Jebrini, Abdullah; Elrefaei, Mohamed

Jarmi, Tambi; Abdelmoneim, Yousif; Li, Zhuo; Jebrini, Abdullah; Elrefaei, Mohamed.

Afiliación

Jarmi T; Department of Transplantation, Mayo Clinic, Jacksonville, FL, United States of America. Electronic address: Jarmi.Tambi@mayo.edu.
Abdelmoneim Y; Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL, United States of America.
Li Z; Health Sciences Research, Mayo Clinic, Jacksonville, FL, United States of America.
Jebrini A; Department of Transplantation, Mayo Clinic, Jacksonville, FL, United States of America.
Elrefaei M; Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL, United States of America.

Transpl Immunol ; 77: 101778, 2023 04.

Article en En | MEDLINE | ID: mdl-36584928

Asunto(s)

Inmunosupresores; Trasplante de Riñón; Basiliximab/uso terapéutico; Inmunosupresores/uso terapéutico; Alemtuzumab; Incidencia; Creatinina; Resultado del Tratamiento; Suero Antilinfocítico/uso terapéutico; Anticuerpos; Rechazo de Injerto/tratamiento farmacológico; Rechazo de Injerto/prevención & control; Receptores de Trasplantes

Palabras clave

Creatinine clearance; De novo donor specific antibodies; Flow cytometry crossmatch; Human leukocyte antigen; Induction therapy; Rejection

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Riñón / Inmunosupresores Tipo de estudio: Incidence_studies / Risk_factors_studies Idioma: En Revista: Transpl Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA / TRANSPLANTE Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google